R7131
RPMI 1640 Amino Acids Solution (50×)
Without L-glutamine, sterile-filtered, BioReagent, suitable for cell culture
Synonym(s):
Amino Acid Supplement
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.75
UNSPSC Code:
12352209
Quality Level
sterility
sterile-filtered
product line
BioReagent
form
liquid
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
shipped in
ambient
storage temp.
2-8°C
General description
RPMI 1640 Amino Acids Solution (50×) serves as an amino acid concentrate to supplement Roswell Park Memorial Institute medium (RPMI)-based mammalian cell culture media.
Application
RPMI 1640 Amino Acids Solution (50×) has been used as a supplement:
- in M9 minimal medium to culture the bacterial strains, SX701 and JE116
- to culture blood neutrophils from lactation cows in vitro
- for amino acid stimulation in amino-acid-free Roswell Park Memorial Institute medium (RPMI) medium to grow HeLa cells
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Nuno Carinhas et al.
BMC systems biology, 5, 34-34 (2011-03-01)
Stoichiometric models constitute the basic framework for fluxome quantification in the realm of metabolic engineering. A recurrent bottleneck, however, is the establishment of consistent stoichiometric models for the synthesis of recombinant proteins or viruses. Although optimization algorithms for in silico
Piero Dalle Pezze et al.
Nature communications, 7, 13254-13254 (2016-11-22)
Amino acids (aa) are not only building blocks for proteins, but also signalling molecules, with the mammalian target of rapamycin complex 1 (mTORC1) acting as a key mediator. However, little is known about whether aa, independently of mTORC1, activate other
Preeti Ashok et al.
Frontiers in bioengineering and biotechnology, 8, 571425-571425 (2020-11-17)
Functional heart cells and tissues sourced from human pluripotent stem cells (hPSCs) have great potential for substantially advancing treatments of cardiovascular maladies. Realization of this potential will require the development of cost-effective and tunable bioprocesses for manufacturing hPSC-based cell therapeutics.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| R7131-1L | 04061837036392 |
| R7131-100ML | 04061836696030 |